FindTrial
Sign In

Effect of Compound Unani formulation in Poly cystic Ovarian Disease

ClinicaL validation of Unani Pharmacopoeial formulation Itrifal e khubs uL Hadeed and Habb e Mudir in Ihtibas al Tamth(Amenorrhea) due to Marz-e-Akyas Khusyatur Rahim (PCOS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091901
Enrollment
110
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N911- Secondary amenorrhea

Interventions

Intervention1: Itrifal Khubs-ul-Hadeed Habb-e-Mudir: Irifal Khubs-ul-Hadeed is a semi solid preparation containing Naushadar(Ammonium chloride) Elaichi khurd ( Elleteria Cardamum) Balcharr (Veleriana

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married/Unmarried patients in the age group of 18-40 years Patients with secondary amenorrrhoea due to PCOS Patients willing to take part in the study

Exclusion criteria

Exclusion criteria: Patients with primary Amenorrhoea and primary ovarian failure Pateints with hyperprolactinaemia Patients with any systemic illness and malignancy Pregnant and lactating woman Patients with bleeding disorders

Design outcomes

Primary

MeasureTime frame
Restoration of Normal Menstrual CycleTimepoint: three months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Mohammed Sheeraz Mushtaque Ahmed

Regional Research Institute of Unani Medicine,Habbak Srinagar

drsheerazmd@gmail.com9797750472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026